NASDAQ · NSTG
Healthcare · Medical - Instruments & Supplies
$0.11
Down-$0.06 (-37.43%)
Updated Oct 6, 2026, 10:38 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NSTG
1M range · 0 trading sessions · Daily adjusted prices
NSTG does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning NSTG.
Company
Market Activity
Research & News
NSTG research
Company profile and research snapshot.
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 27, 2023 | Canaccord Genuity | Buy | — |
| Nov 27, 2023 | JP Morgan | Neutral | — |
| Nov 21, 2023 | Baird | Neutral | — |
| Nov 20, 2023 | TD Cowen | Market Perform | — |
| Oct 24, 2023 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
Zacks Investment Research · Feb 8, 2024
Haemonetics (HAE) delivered earnings and revenue surprises of 7.22% and 4.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Benzinga · Feb 5, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 200 points on Monday. The Dow traded down 0.53% to 38,450.28 while the NASDAQ fell 0.11% to 15,612.52. The S&P 500 also fell, dropping, 0.16% to 4,950.80. Check This Out: Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday Leading and Lagging Sectors Information technology shares rose by 0.6% on Monday. In trading on Monday, materials shares fell by 2.4%. Top Headline Caterpillar Inc (NYSE: CAT) posted better-than-expected earnings for its fourth quarter on Monday. Caterpillar reported a fourth-quarter fiscal 2023 revenue increase of 3% year-over-year to $17.07 billion, versus the consensus of $17.11 billion. CAT’s adjusted earnings of $5.23 per share, compared to $3.86 a year ago, topped the consensus of $4.75. Equities Trading UP Everbridge, Inc. (NASDAQ: EVBG) shares shot up 19% to $28.19 after the company announced it will be acquired by Thoma Bravo for $1.5 billion. Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) got a boost, surging 74% to $30.42 after the company announced interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet AMD patients with severe disease activity and a high treatment burden. Chenghe ...
Benzinga · Feb 5, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday. The Dow traded down 1.04% to 38,253.72 while the NASDAQ fell 0.86% to 15,493.97. The S&P 500 also fell, dropping, 0.70% to 4,923.81. Check This Out: Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday Leading and Lagging Sectors Health care shares rose by 0.4% on Monday. In trading on Monday, materials shares fell by 2.6%. Top Headline The ISM services PMI for the US rose to 53.4 in January versus 50.5 in the prior month, and topping market estimates of 52. Equities Trading UP Everbridge, Inc. (NASDAQ: EVBG) shares shot up 18% to $28.12 after the company announced it will be acquired by Thoma Bravo for $1.5 billion. Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) got a boost, surging 73% to $30.30 after the company announced interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet AMD patients with severe disease activity and a high treatment burden. Chenghe Acquisition Co. (NASDAQ: CHEA) shares were also up, gaining 63% to $8.97 after shareholders on Friday voted to approve ...
Benzinga · Feb 5, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Monday. Following the market opening Monday, the Dow traded down 0.41% to 38,494.03 while the NASDAQ fell 0.15% to 15,605.04. The S&P 500 also fell, dropping, 0.18% to 4,949.49. Check This Out: Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday Leading and Lagging Sectors Health care shares rose by 0.6% on Monday. In trading on Monday, materials shares fell by 2.4%. Top Headline McDonald’s Corporation (NYSE: MCD) posted weaker-than-expected sales for its fourth quarter. McDonald’s reported adjusted EPS of $2.95, beating the consensus of $2.82. Sales of $6.41 billion, up 8% Y/Y (6% in constant currencies), fell slightly short of the consensus of $6.45 billion. Equities Trading UP Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares shot up 104% to $0.4673. Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) got a boost, surging 91% to $33.42 after the company announced interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet AMD patients with severe disease activity and a high treatment burden. Chenghe Acquisition Co. (NASDAQ: CHEA) shares ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NSTG.
No results
No recent SID articles mention NSTG.
